Sponsors for KIN Research:

Google Groups
Subscribe to Medical Schools & Immunology Programs
Visit this group


The KIN Consulting & Research Services Company

WWW The Chairman's Spider Web


                    Chairman's Spider Web

  The Medical Industry is comprised of a web of scientists around the world.    Some are based in companies,  while others are based in universities.    The Chairman has built a spider web that links leading Universities and Companies together with Investors.   Contact the Chairman for further details.

   The best case scenario is a university adopts the educational curricullum, the students take the courses, graduate, take on the research, and finally develope the KIN Intravenous Solution. We can ramp up the timeline with your investments and donations. Take a look at

New!! The KIN Promotional Gear

                                   The Project, the Investors, and the Scientists:

   We need to pave the way for the production and financing of the KIN Intravenous Solution (cloned white blood cells & glucose). The government has provided funding for the public education and actual production of the KIN Intravenous Solution, with regards to the production of cloned white blood cells. (Appropriations Committee Labor, Health, & Human Services )

   We are currently trying to raise finance from the financial markets via our Medical Concept Roadshow for "Cloning Lymphocytes":


"NIH's Application for Money"


New International Finance Corp. IFC's Application for Money"

  We have contacted the Portfolio Managers from the following Mutual Funds:

A) Erin Xie   (Blackrock Lead Portfolio Manager)
B) Evan Mcculloch   (Franklin Lead Portfolio Manager)
C) Albert Aguiar    ( Merrill Lead Portfolio Manager)
D) Dr. Ulf Tossman   (PrivateEquity)
E) Cliff Goldstein    (AMIDEX Lead Portfolio Manager)
F) J.C. Waller    (ICON Lead Portfolio Manager)
G) Liu-Er Chen    (Evergreen Lead Portfolio Manager )
H) Donald Nesbitt    (North Track Lead Portfolio Manager )
I) Samuel Isaly    (Eaton Vance Lead Portfolio Manager)
J) Suresh Rajagopa    (Munder Lead Portfolio Manager)

We have also contacted the following Companies:

A) Kevin Sharer   (Amgen) B) Stephen Fodor    (Affymetrix) C) Michael Dougherty    (Adolor) D) Troy J Powell    (ArdusMedical) E) Alan Cooke   (AMARIN) F) R. David Yost    (Amerisourcebergen) G) Chris Yochim    (Astrazeneca) H) Jim Mullen    (Biogen IDEC) I) Anthony Griffo    (Brad Pharm) J) Peter Dolan   (Bristol Myers Squibb) K) Joe Papa   (CardinalBiotech) J) Kathy Ordonez    (Celera) L) Dr. Arthur Levinson    (Genentech) H) Rajesh Shrotriya    (Spectrumpharm) I) Alex Gorsky    (Novartis)

Medical Schools & Genebanks:

Good Excellent
13. INSERM U454 Excellent
70. Nothwestern University Feinburgh School of Medicine
   A. Nothwestern University Feinberg School of Medicine Department of Microbiology-Immunology.

Organizations for promoting Medical Science:

1. The Journal of Immunology

Discussion Boards :


Khalid "Kal" I. Natto
The Chairman of the Board
The KIN Consortium
Telephone and Voicemail Number: 1(413)-370-2346
Fax Number: 1(610)-300-5883

Solution Graphics

First name:
Last name:
Email address:
Address 1:
Address 2:
Zip code:
Request information

Disclaimer of Warranty and Limitation of Liability
The information, products and services on this web site or letter are provided on an "AS IS," "WHERE IS" and "WHERE AVAILABLE" basis.  The KIN Consortium does not warrant the information or services provided herein or your use of this web site generally, either expressly or impliedly, for any particular purpose and expressly disclaims any implied warranties, including but not limited to, warranties of title, non-infringement, merchantability or fitness for a particular purpose. The KIN Consortium  will not be responsible for any loss or damage that could result from interception by third parties of any information or services made available to you via this web site. Although the information provided to you on this web site is obtained or compiled from sources we believe to be reliable, The KIN Consortium  cannot and does not guarantee the accuracy, validity, timeliness or completeness of any information or data made available to you for any particular purpose. Neither The KIN Consortium , nor any of its affiliates, directors, officers or employees, nor any third party vendor, will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or interruption of this web site, or resulting from the act or omission of any other party involved in making this web site, the data contained herein or the products or services offered on this web site available to you, or from any other cause relating to your access to, inability to access, or use of the web site or these materials, whether or not the circumstances giving rise to such cause may have been within the control of The KIN Consortium  or of any vendor providing software or services. In no event will The KIN Consortium  or any such parties be liable to you, whether in contract or tort, for any direct, special, indirect, consequential or incidental damages or any other damages of any kind even if The KIN Consortium  or any other such party has been advised of the possibility thereof. This limitation on liability includes, but is not limited to, the transmission of any viruses which may infect a user's equipment, failure of mechanical or electronic equipment or communication lines, telephone or other interconnect problems (e.g., you cannot access your internet service provider), unauthorized access, theft, operator errors, strikes or other labor problems. The KIN Consortium  cannot and does not guarantee continuous, uninterrupted or secure access to the web site.

Proprietary Rights
All right, title and interest in this web site and any content contained herein is the exclusive property of The KIN Consortium , except as otherwise stated. Unless otherwise specified, this web site is for your personal and non-commercial use only and you may print, copy and download any information or portion of this web site for your personal use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, frame, create derivative works from, transfer, or otherwise use in any other way for commercial or public purposes in whole or in part any information, software, products or services obtained from this web site, except for the purposes expressly provided herein, without The KIN Consortium's prior written approval. If you copy or download any information or software from this web site, you agree that you will not remove or obscure any copyright or other notices or legends contained in any such information.

The KIN Consortium and other trademarks and service marks referenced herein are trademarks and service marks of The KIN Consortium . The names of other companies and third-party products or services mentioned herein may be the trademarks or service marks of their respective owners. You are prohibited from using any marks for any purpose including, but not limited to use as metatags on other pages or sites on the World Wide Web without the written permission of The KIN Consortium  or such third party, which may own the marks.

Pursuant to Section 512(c)(2) of the Copyright Act, The KIN Consortium  designates the following agent to receive notifications of claimed infringement: Khalid I Natto, The KIN Consortium , Email:
kalnatto2000@yahoo.com, Website: http://khalidnatto.tripod.com 

Use of Links
This web site contains links to third party web sites. These links are provided only as a convenience. The inclusion of any link is not and does not imply an affiliation, sponsorship, endorsement, approval, investigation, verification or monitoring by The KIN Consortium of any information contained in any third party web site. In no event shall The KIN Consortium be responsible for the information contained on that site or your use of or inability to use such site. You should also be aware that the terms and conditions of such site and the site's privacy policy may be different from those applicable to your use of this web site.

For New Websites Contact Webmaster at Email: khalidnatto@gmail.com

Feedback, subscriptions, ideas? Email: kalnatto2000@yahoo.com